Drug Database
Back to search

Poland· PL-100065516

Tanakan

A ginkgoblatt product containing ginkgo folii extractum siccum, registered in Poland by MAYOLY PHARMA FRANCE. The same ATC class is registered in 6 of our 19 countries.

ATC N06DX02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedTanakanATCN06DX02REGISTER NO.PL-100065516PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ginkgo folii extractum siccumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ginkgoblatt is registered in 6 of 19 countries.

Countries holding a registration under ATC N06DX02 (ginkgoblatt), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose
Search ginkgoblatt products by name

Ginkgoblatt · ATC N06DX02

6 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Polandprice
  • Spainprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Ginkgo folii extractum siccum
Manufacturer
MAYOLY PHARMA FRANCE
Country
Poland (PL)
ATC code
N06DX02
ATC class
Ginkgoblatt
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909990049615
  • gtin
    05909990049622

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

22 interactions on record for ginkgoblatt.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ginkgoblatt against other medicinesHow interaction checks work

Ginkgoblatt · interactions on record

22 records

22 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same class

Other records under N06DX02

Ginkgoblatt, as other registers publish it.

All ginkgoblatt products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/eb80bae8-5ee5-4357-a3ff-a06dd0df6c4c
GET /v1/drugs/eb80bae8-5ee5-4357-a3ff-a06dd0df6c4c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "40 mg",
  "packaging": "05909990049615 ¦ OTC ¦ 9861\n30 tabl.\n05909990049622 ¦ OTC ¦ 9862\n90 tabl.",
  "substance": "Ginkgo bilobae extractum 40 mg",
  "common_name": "Ginkgo folii extractum siccum",
  "pl_product_id": "100065516",
  "pozwolenie_nr": "00496",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about ginkgoblatt.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console